Peptides is a very broad category, so each one lies on a spectrum ranging from decades of human research to never been tested in humans. BPC-157 and TB-500, the two peptides generating a lot of attention right now, sit firmly in the potentially promising animal studies category
Emulating a randomized clinical trial with real-world data to evaluate the effect of antidepressant use in PTSD patients with high suicide risk
Other important safety information Do not use B12/MIC if you are currently pregnant, breastfeeding or plan to become pregnant or breastfeed
doi: 10.1016/j.lwt.2022.113634 195 YamadaY.MurakiA.OieM.KanegawaN.OdaA.SawashiY.et al
Reading the dates as a sequence: a clerical issue (a withdrawn nomination), a three-week regulatory gap (April 22 to May 5), a clarification, an updated reference document (May 14), and a future PCAC review that will run alongside the broader peptide policy fight already on the agency's calendar